A publicly owned pharmaceutical industry is the best solution to stopping drug shortages.
by Dana Brown and Christopher Morten, Stat
Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and doctors to make difficult decisions to delay or ration first-line treatments, or accept second-best treatments. ADHD treatments, antibiotics, children’s acetaminophen, and many other critical medicines are also in short supply.
But most of the solutions being discussed are just Band-Aids on a broken system. They would do nothing to transform the incentives that routinely produce shortages and other market failures.

What we really need — for the health of our economy and society — is a robust public option in pharmaceuticals that produces and distributes essential medicines, such as cancer treatments. Publicly accountable public agencies can assure resilient supply chains and offer medicines at or even below cost, because keeping people healthy without bankrupting them in the process is good for society (and cost-effective to boot). This already happens at scales large and small all over the world, including Brazil, Sweden, Cuba, the U.K., India, Thailand, and more.
Recent Posts
The Dark Money Machine Shaping Democrats’ Mandate
November 19, 2026
Take Action Now Banks, cryptocurrency firms, and the Israel lobby poured millions into super PACs tied to Democratic caucuses. Now those groups are…
Can Progressives Push Hakeem Jeffries to the left?
November 18, 2026
Take Action Now The likely next House speaker has a record of defending corporate interests. His fellow Democrats must fight for Medicare for All and…
Trump Says Nationwide Outages Are “Fine” as More Systems Go Down
November 17, 2026
Take Action Now Two additional outages occurred after Trump’s comments, affecting the NSA and Apple products.By Chris Walker, Truthout President…
Say No to U.S.-Israel Military Integration
November 16, 2026
Take Action Now We should be ending U.S. complicity in what the U.N. Commission of Inquiry, human rights organizations, genocide scholars and many…




